To screen for gastroenterological malignancies in dialysis patients, we use
d the fecal occult blood test, examined the upper and lower gastrointestina
l tract, and used abdominal ultrasonography in 178 patients starting dialys
is (171 on hemodialysis and 7 on continuous ambulatory peritoneal dialysis
(CAPD)) and 34 patients on maintenance dialysis (27 on hemodialysis and 7 o
n CAPD). Screening disclosed ten cancers tone esophageal cancer, three gast
ric cancers, four colorectal cancers, and two hepatocellular carcinomas) in
9 of the patients starting dialysis. Six cancers tone esophageal, three ga
stric, one colorectal, and one renal) were detected in 5 of the patients on
maintenance dialysis. Since an increased incidence of malignancy has been
reported in dialysis patients, gastroenterological screening appears to be
worthwhile.